Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser

Showing results (121-130 of 14,271) with videos related to

Pageof 1,428
Sort By:
Animal Reproduction|February 14, 2012
Uterine microRNA signature and consequence of their dysregulation in uterine disordersNasser Chegini
Current Drug Delivery|June 24, 2011
Quick-release bromocriptine for treatment of type 2 diabetesNasser Mikhail
Vascular Health and Risk Management|April 2, 2009
Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potentialNasser Mikhail
Supplement to International Journal of Gynecology and Obstetrics|January 1, 1989
Commentary on pain management during abortion from a Latin American physician's perspectiveJ Nasser
JAMA|October 9, 2002
Insulin resistance and HIV-related lipoatrophyNasser Mikhail
Archives of Internal Medicine|February 13, 2003
The use of niacin in diabetes mellitusNasser Mikhail
Archives of Internal Medicine|January 16, 2008
Cardiovascular safety of low-dose rosiglitazoneNasser Mikhail
World Journal of Diabetes|December 30, 2016
Place of technosphere inhaled insulin in treatment of diabetesNasser Mikhail
Lancet (London, England)|September 6, 2003
Comments on the MRC/BHF Heart Protection StudyNasser Mikhail
Southern Medical Journal|September 30, 2003
Lessons learned from the Women's Health Initiative StudyNasser Mikhail
Pageof 1,428

Showing results (121-130 of 14,271) with videos related to

Sort By:
Pageof 1,428
Animal Reproduction|February 14, 2012
Uterine microRNA signature and consequence of their dysregulation in uterine disordersNasser Chegini
Current Drug Delivery|June 24, 2011
Quick-release bromocriptine for treatment of type 2 diabetesNasser Mikhail
Vascular Health and Risk Management|April 2, 2009
Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potentialNasser Mikhail
Supplement to International Journal of Gynecology and Obstetrics|January 1, 1989
Commentary on pain management during abortion from a Latin American physician's perspectiveJ Nasser
JAMA|October 9, 2002
Insulin resistance and HIV-related lipoatrophyNasser Mikhail
Archives of Internal Medicine|February 13, 2003
The use of niacin in diabetes mellitusNasser Mikhail
Archives of Internal Medicine|January 16, 2008
Cardiovascular safety of low-dose rosiglitazoneNasser Mikhail
World Journal of Diabetes|December 30, 2016
Place of technosphere inhaled insulin in treatment of diabetesNasser Mikhail
Lancet (London, England)|September 6, 2003
Comments on the MRC/BHF Heart Protection StudyNasser Mikhail
Southern Medical Journal|September 30, 2003
Lessons learned from the Women's Health Initiative StudyNasser Mikhail
Pageof 1,428